QNTM
Quantum BioPharma Ltd.
NASDAQ: QNTM · HEALTHCARE · BIOTECHNOLOGY
$5.73
+1.42% today
Updated 2026-04-30
Market cap
$31.77M
P/E ratio
—
P/S ratio
91.86x
EPS (TTM)
$-8.20
Dividend yield
—
52W range
$2 – $38
Volume
0.5M
Quantum BioPharma Ltd. (QNTM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-63.00 | $-27238.00 | $-119176.00 | $-13.58M | $-13.71M | $-19.13M | $-20.75M | $-28.33M | $-10.83M | $-6.88M | $-8.38M |
| Capital expenditures | $0.00 | $0.00 | $6.09M | $2.96M | $293126.00 | $3.00 | $500000.00 | $363958.00 | $2.00 | $1.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $2.38M | $4.73M | $12.08M | $8.05M | $7.44M | $1.53M | $3.84M | $152214.00 | $2.95M |
| Free cash flow | $-63.00 | $-27238.00 | $-6.21M | $-16.54M | $-14.01M | $-19.13M | $-21.25M | $-28.70M | $-10.83M | $-6.88M | $-8.38M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — |